Biotechnology company Recursion Pharmaceuticals Inc. $RXRX, based in Salt Lake City, is venturing into a groundbreaking initiative that could reshape the pharmaceutical landscape. Leveraging artificial intelligence in drug development, Recursion is contemplating a subscription model similar to Amazon Prime for the sale of its medication. This strategy has the potential to significantly impact the pharmaceutical industry and the distribution methods of medical products.

The decentralized lending platform Colend Protocol, built on the Core blockchain, has unveiled its roadmap for 2025. The primary goals and initiatives outlined in this plan are aimed at enhancing the practicality and sustainability of the decentralized finance (DeFi) ecosystem. This article explores the key elements of Colend’s new strategy, which could have a significant impact on the platform's development and the broader DeFi market.